📊 Biotech Holds Modest Gains

Positive Phase 2 feedback ignites sharp move in neuro-focused biotech

In partnership with

Good Morning Investors,

The Dow Jones U.S. Semiconductors Index rose (+0.3%) in response to AI spending and China deal fueling growth advancements. NASDAQ Biotechnology also nudged up (+0.2%) despite Options Traders appearing to underplay the small-cap rally.

July's surge in wholesale inflation has slowed the stock surge and slight doubts are cast on the possibility of a rate cut with a higher bar from Fed. With PPI data sending stocks lower, experts are considering if the Fed could cut half a point in September.

Trump's pick for the next Fed chair, a decision believed to have potential market impact, is eagerly anticipated.

Matthias Schneider
Editor at Analytica Investor

Subscribe to keep reading

This content is free, but you must be subscribed to Analytica Investor to continue reading.

Already a subscriber?Sign in.Not now